Neuroscience

Do microglia hold the key to stop Alzheimer's disease?

A Leuven research team led by Prof. Bart De Strooper (VIB-KU Leuven, UK DRI) studied how specialized brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer's. ...

Alzheimer's disease & dementia

Study points to new method to deliver drugs to the brain

Researchers at the University of Rochester Medical Center (URMC) have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of ...

Alzheimer's disease & dementia

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological researchers at Rush University Medical Center, who published ...

Alzheimer's disease & dementia

Here's what we think Alzheimer's does to the brain

Around 50m people worldwide are thought to have Alzheimer's disease. And with rapidly ageing populations in many countries, the number of sufferers is steadily rising.

Alzheimer's disease & dementia

Structural analysis of relevant drug targets for Alzheimer's disease

Alzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant. In AD, the beta-amyloid precursor protein (β-APP) that ...

Alzheimer's disease & dementia

Never before seen images of early stage Alzheimer's disease

Researchers at Lund University in Sweden have used the MAX IV synchrotron in Lund – the strongest of its kind in the world - to produce images that predate the formation of toxic clumps of beta-amyloid, the protein believed ...

Alzheimer's disease & dementia

Gut bacteria may play a role in Alzheimer's disease

New research from Lund University in Sweden has shown that intestinal bacteria can accelerate the development of Alzheimer's disease. According to the researchers behind the study, the results open up the door to new opportunities ...

Alzheimer's disease & dementia

New worm strain to facilitate study of Alzheimer's disease

Researchers from Yale-NUS College have partnered with researchers from the National University of Singapore (NUS) and SingHealth Group to develop a novel Caenorhabditis elegans (C. elegans) worm strain which expresses an ...

Alzheimer's disease & dementia

Alzheimer's: Nicotinic receptors as a new therapeutic target

Several scientific studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attributed to nicotine - which ...

page 8 from 10